Authors
Ariel D Szvalb, Sebastian Wurster, Takahiro Matsuo, Teny M John, Adam G Stewart, Sung-Yeon Cho, Ying Jiang, Dimitrios P Kontoyiannis
Published in
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Jun 29, 2026. Epub Jun 29, 2026.
Abstract
Given competing death causalities among hematological malignancy patients with invasive aspergillosis (IA), we assessed IA-attributable, contributable, and all-cause mortalities in patients with culture-confirmed IA. Although attributable mortality decreased, contributable and all-cause mortalities remained high. Our data suggest that improving survival would require host augmentation, in addition to improved antifungals.
PMID:
42372090
Bibliographic data and abstract were imported from PubMed on 30 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0